Moreover, among these patients, survival analysis of 24 EGFR‐mutant NSCLC patients revealed that those with high CD73 expression had significantly worse overall survival (OS) than those with low expression (Figure S6a, Supporting Information). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.